{"lead_paragraph": "J. Michael Pearson, who is also Valeant\u2019s chairman, was hospitalized in late December with what the pharmaceutical giant has described as pneumonia.", "pub_date": "2016-01-26T00:00:00Z", "slideshow_credits": null, "byline": {"person": [{"lastname": "POLLACK", "role": "reported", "rank": 1, "organization": "", "firstname": "Andrew"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "section_name": "Business Day", "snippet": "J. Michael Pearson, who is also Valeant\u2019s chairman, was hospitalized in late December with what the pharmaceutical giant has described as pneumonia.", "multimedia": [{"subtype": "wide", "width": 190, "height": 126, "type": "image", "url": "images/2016/01/26/business/26valeant-web1/26valeant-web1-thumbWide.jpg", "legacy": {"wide": "images/2016/01/26/business/26valeant-web1/26valeant-web1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}}, {"subtype": "xlarge", "width": 600, "height": 450, "type": "image", "url": "images/2016/01/26/business/26valeant-web1/26valeant-web1-articleLarge.jpg", "legacy": {"xlargeheight": "450", "xlarge": "images/2016/01/26/business/26valeant-web1/26valeant-web1-articleLarge.jpg", "xlargewidth": "600"}}, {"subtype": "thumbnail", "width": 75, "height": 75, "type": "image", "url": "images/2016/01/26/business/26valeant-web1/26valeant-web1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/01/26/business/26valeant-web1/26valeant-web1-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}}], "blog": [], "type_of_material": "News", "headline": {"main": "Valeant Chief Says Timing of His Return to Work Is Unclear", "print_headline": "Timing of Return to Work Is Unclear for Valeant Chief"}, "keywords": [{"rank": "1", "name": "organizations", "is_major": "Y", "value": "Valeant Pharmaceuticals International Inc"}, {"rank": "2", "name": "persons", "is_major": "Y", "value": "Pearson, John Michael (1959- )"}, {"rank": "3", "name": "subject", "is_major": "N", "value": "Drugs (Pharmaceuticals)"}, {"rank": "4", "name": "persons", "is_major": "N", "value": "Ingram, Robert A"}, {"rank": "5", "name": "persons", "is_major": "N", "value": "Schiller, Howard B"}], "web_url": "http://www.nytimes.com/2016/01/26/business/valeant-chief-michael-pearson.html", "print_page": "2", "source": "The New York Times", "news_desk": "Business", "abstract": "Valeant Pharmaceuticals chief executive J Michael Pearson says he is 'on road to recovery' following hospitalization, but is uncertain when he will return to work.", "word_count": "350", "_id": "56a6283e38f0d81529067dfc", "subsection_name": null}